HTG Molecular Diagnostics, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
HTG Molecular Diagnostics, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$5.05 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2023-05-11
- HTG Molecular Diagnostics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-03-31 was -$5.05M.
- HTG Molecular Diagnostics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-12-31 was -$4.69M.
- HTG Molecular Diagnostics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was -$4.52M.
- HTG Molecular Diagnostics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-06-30 was -$5.89M.
- HTG Molecular Diagnostics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$21.59M.
- HTG Molecular Diagnostics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$17.15M.
- HTG Molecular Diagnostics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$20.87M.
- HTG Molecular Diagnostics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$19.30M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$5.05M 10-Q · filed 2023-05-11 | -$9.75M derived: sum of 2 quarters · filed 2023-05-11 | -$14.26M derived: sum of 3 quarters · filed 2023-05-11 | -$20.15M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | -$4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$9.21M derived: sum of 2 quarters · filed 2023-03-30 | -$15.10M derived: sum of 3 quarters · filed 2023-03-30 | -$21.59M 10-K · filed 2023-03-30 |
| 2022-09-30 | -$4.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$10.40M derived: sum of 2 quarters · filed 2022-11-10 | -$16.90M 10-Q · filed 2022-11-10 | -$22.09M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-06-30 | -$5.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$12.39M 10-Q · filed 2022-08-12 | -$17.58M derived: sum of 3 quarters · filed 2023-05-11 | -$22.07M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-03-31 | -$6.50M 10-Q · filed 2023-05-11 | -$11.69M derived: sum of 2 quarters · filed 2023-05-11 | -$16.18M derived: sum of 3 quarters · filed 2023-05-11 | -$18.79M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$5.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$9.68M derived: sum of 2 quarters · filed 2023-03-30 | -$12.30M derived: sum of 3 quarters · filed 2023-03-30 | -$17.15M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$4.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$7.11M derived: sum of 2 quarters · filed 2022-11-10 | -$11.95M 10-Q · filed 2022-11-10 | -$16.24M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$7.46M 10-Q · filed 2022-08-12 | -$11.75M derived: sum of 3 quarters · filed 2022-08-12 | -$17.17M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$4.85M 10-Q · filed 2022-05-12 | -$9.14M derived: sum of 2 quarters · filed 2022-05-12 | -$14.55M derived: sum of 3 quarters · filed 2022-05-12 | -$20.26M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$4.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$9.70M derived: sum of 2 quarters · filed 2022-03-29 | -$15.41M derived: sum of 3 quarters · filed 2022-03-29 | -$20.87M 10-K · filed 2022-03-29 |
| 2020-09-30 | -$5.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$11.12M derived: sum of 2 quarters · filed 2021-11-10 | -$16.58M 10-Q · filed 2021-11-10 | -$20.97M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$5.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$11.17M 10-Q · filed 2021-08-12 | -$15.56M derived: sum of 3 quarters · filed 2021-08-12 | -$20.30M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$5.46M 10-Q · filed 2021-05-13 | -$9.85M derived: sum of 2 quarters · filed 2021-05-13 | -$14.59M derived: sum of 3 quarters · filed 2021-05-13 | -$19.38M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$9.13M derived: sum of 2 quarters · filed 2021-03-25 | -$13.93M derived: sum of 3 quarters · filed 2021-03-25 | -$19.30M 10-K · filed 2021-03-25 |
| 2019-09-30 | -$4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$9.54M derived: sum of 2 quarters · filed 2020-11-10 | -$14.91M 10-Q · filed 2020-11-10 | -$17.04M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | -$4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$10.17M 10-Q · filed 2020-08-11 | -$12.30M derived: sum of 3 quarters · filed 2020-08-11 | -$17.14M derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | -$5.37M 10-Q · filed 2020-05-13 | -$7.50M derived: sum of 2 quarters · filed 2020-05-13 | -$12.34M derived: sum of 3 quarters · filed 2020-05-13 | -$16.44M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | -$2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$6.97M derived: sum of 2 quarters · filed 2020-03-25 | -$11.07M derived: sum of 3 quarters · filed 2020-03-25 | -$16.45M 10-K · filed 2020-03-25 |
| 2018-09-30 | -$4.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$8.95M derived: sum of 2 quarters · filed 2019-11-12 | -$14.33M 10-Q · filed 2019-11-12 | -$16.25M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$9.48M 10-Q · filed 2019-08-06 | -$11.40M derived: sum of 3 quarters · filed 2019-08-06 | -$16.79M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$5.38M 10-Q · filed 2019-05-09 | -$7.30M derived: sum of 2 quarters · filed 2019-05-09 | -$12.68M derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | -$1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$7.30M derived: sum of 2 quarters · filed 2019-03-07 | -$18.96M 10-K · filed 2019-03-07 | |
| 2017-09-30 | -$5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$17.04M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$11.66M 10-Q · filed 2018-08-09 |